Association of insurance types and outcomes in acute promyelocytic leukemia

Department

Internal Medicine

Document Type

Article

Publication Title

Leukemia & Lymphoma

Abstract

Understanding the association between insurance status and survival in an evolving US healthcare system remains a challenge but is essential to address healthcare disparities. We utilized National Cancer Database to evaluate the effects of insurance type on one-month mortality and overall survival (OS) in patients with acute promyelocytic leukemia. Among patients < 65 years, one-month mortality was worse for uninsured patients and patients with Medicare compared to patients with private insurance. OS was similar between patients with private insurance and uninsured patients but worse for patients with Medicare and Medicaid/other government insurance. In multivariate analysis, older age and greater comorbidity burden conferred worse OS. For patients ≥ 65 years, insurance type did not affect one-month mortality and OS. Older age, greater comorbidity burden, and treatment at non-academic centers conferred worse one-month mortality and OS. Our results highlight healthcare disparities based on insurance types for both younger and older patients.

First Page

2627

Last Page

2635

DOI

10.1080/10428194.2022.2090554

Volume

63

Issue

11

Publication Date

11-2022

Publisher

Taylor & Francis

Comments

Record updated with published article citation 2022-12-05 LB.

Published online ahead of print 2022-06-23.

PubMed ID

35737360

Link to Full Text

Share

COinS